Disruptive Power Of CTCA In A DGH’s Endeavour Towards Value Based Health Care

Abstract

Introduction: In 2016, NICE CG 95 was revised to recommend CT coronary angiography (CTCA) as the first line test for angina or non-anginal chest pain with ECG abnormalities. Additional capacity modelling, to deliver this guideline, performed by the British Society of Cardiac Imaging, demonstrated a mismatch with current capacity. There is an additional disparity between a district general hospital (DGH) and tertiary centres to deliver CTCA in England. The initial point of contact for patients will be their local DHG. 5 years on, we sought to assess the local impact CTCA has had; to establish if it truly has offered an acceptable alternative to invasive coronary angiography (ICA) in our population of approximately 800,000, and to predict its fiscal impact.